Design, Synthesis and Evaluation of New Chromone-derived Aminophosphonates As Potential Acetylcholinesterase Inhibitor

Overview

Journal Mol Divers

Date 2020 Mar 4

PMID 32124162

Citations 8

Authors

Sarfaraz Shaikh

Pratik Dhavan

M M V Ramana

B L Jadhav

Affiliations

Soon will be listed here.

Abstract

A series of novel N-substituted α-aminophosphonates-bearing chromone moiety were synthesized and evaluated for acetylcholinesterase (AChE), butyrylcholinesterase (BuChE) activities and antioxidant properties. Porcine pancreatic lipase was employed as a catalyst. Inhibitory activity against AChE ranged between 0.103 and 5.781 µM, whereas for BuChE, activities ranged between 8.619 and 18.789 µM. The results show that among the various synthesized compounds, strongest AChE inhibition was found for the compound containing aliphatic amine analogs, while in case of BuChE, aromatic amines showed better activity as compared to aliphatic amines. Compound 4j was found to be the most potent inhibitor of AChE with an IC value of 0.103 ± 0.24 μM and inhibited AChE through mixed-type inhibition. Compound 4j was twofolds more potent than tacrine, 35-folds potent than galantamine and 50-folds potent than rivastigmine. Also, docking study revealed that compound 4j binds to both the peripheral anionic site and catalytic anionic site of AChE and BuChE. The antioxidant activities of synthesized compounds were performed against 2,2-diphenyl-1-picrylhydrazyl and hydrogen peroxide scavenging. DNA nicking activity of selected compounds also suggested that the compounds do not harm plasmid DNA pBR322. Compound 4j also showed significant DNA damage protection activity. Novel N-substituted α-aminophosphonates bearing chromone moiety were synthesized and evaluated for anti-acetylcholinesterase, anti-butyrylcholinesterase, antioxidant and DNA damage activities.

Citing Articles

Asymmetric Transfer Hydrogenation as a Key Step in the Synthesis of the Phosphonic Acid Analogs of Aminocarboxylic Acids.

Dinhof T, Kalina T, Stankovic T, Braunsteiner K, Rohrbach P, Turhan E Chemistry. 2023; 29(72):e202302171.

PMID: 37461839 PMC: 10947287. DOI: 10.1002/chem.202302171.

Synthesis of Enantiomerically Enriched Protected 2-Amino-, 2,3-Diamino- and 2-Amino-3-Hydroxypropylphosphonates.

Trocha A, Piotrowska D, Glowacka I Molecules. 2023; 28(3).

PMID: 36771131 PMC: 9921368. DOI: 10.3390/molecules28031466.

Resveratrol-Maltol and Resveratrol-Thiophene Hybrids as Cholinesterase Inhibitors and Antioxidants: Synthesis, Biometal Chelating Capability and Crystal Structure.

Mlakic M, Fodor L, Odak I, Horvath O, Lovric M, Baric D Molecules. 2022; 27(19).

PMID: 36234916 PMC: 9573353. DOI: 10.3390/molecules27196379.

Synthesis of Novel 2,3-Dihydro-1,5-Benzothiazepines as α-Glucosidase Inhibitors: , , Kinetic, SAR, Molecular Docking, and QSAR Studies.

Mehmood R, Mughal E, Elkaeed E, Obaid R, Nazir Y, Al-Ghulikah H ACS Omega. 2022; 7(34):30215-30232.

PMID: 36061741 PMC: 9435035. DOI: 10.1021/acsomega.2c03328.

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase.

Obaid R, Naeem N, Mughal E, Al-Rooqi M, Sadiq A, Jassas R RSC Adv. 2022; 12(31):19764-19855.

PMID: 35919585 PMC: 9275557. DOI: 10.1039/d2ra03081k.

References

Kung H, Lee C, Zhuang Z, Kung M, Hou C, Plossl K . Novel stilbenes as probes for amyloid plaques. J Am Chem Soc. 2001; 123(50):12740-1. DOI: 10.1021/ja0167147. View

Viau C, Curren R, Wallace K . Cytotoxicity of tacrine and velnacrine metabolites in cultured rat, dog and human hepatocytes. Drug Chem Toxicol. 1993; 16(3):227-39. DOI: 10.3109/01480549309081817. View

Gaspar A, Matos M, Garrido J, Uriarte E, Borges F . Chromone: a valid scaffold in medicinal chemistry. Chem Rev. 2014; 114(9):4960-92. DOI: 10.1021/cr400265z. View

Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H . Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol. 1997; 53(11):1649-57. DOI: 10.1016/s0006-2952(97)82453-7. View

Khan K, Ambreen N, Mughal U, Jalil S, Perveen S, Choudhary M . 3-Formylchromones: potential antiinflammatory agents. Eur J Med Chem. 2010; 45(9):4058-64. DOI: 10.1016/j.ejmech.2010.05.065. View

Jackson S, Schoenwaelder S . Antiplatelet therapy: in search of the 'magic bullet'. Nat Rev Drug Discov. 2003; 2(10):775-89. DOI: 10.1038/nrd1198. View

Miean K, Mohamed S . Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 2001; 49(6):3106-12. DOI: 10.1021/jf000892m. View

Bruhlmann C, Ooms F, Carrupt P, Testa B, Catto M, Leonetti F . Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem. 2001; 44(19):3195-8. DOI: 10.1021/jm010894d. View

Demmer C, Krogsgaard-Larsen N, Bunch L . Review on modern advances of chemical methods for the introduction of a phosphonic acid group. Chem Rev. 2011; 111(12):7981-8006. DOI: 10.1021/cr2002646. View

10.

Sienczyk M, Oleksyszyn J . Irreversible inhibition of serine proteases - design and in vivo activity of diaryl alpha-aminophosphonate derivatives. Curr Med Chem. 2009; 16(13):1673-87. DOI: 10.2174/092986709788186246. View

11.

ATHERTON F, HASSALL C, Lambert R . Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid. J Med Chem. 1986; 29(1):29-40. DOI: 10.1021/jm00151a005. View

12.

Valasani K, Hu G, Chaney M, Yan S . Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease. Chem Biol Drug Des. 2012; 81(2):238-49. PMC: 3640359. DOI: 10.1111/cbdd.12068. View

13.

Fernandez-Bachiller M, Perez C, Monjas L, Rademann J, Rodriguez-Franco M . New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. J Med Chem. 2012; 55(3):1303-17. DOI: 10.1021/jm201460y. View

14.

Hu W, Guan Z, Deng X, He Y . Enzyme catalytic promiscuity: The papain-catalyzed Knoevenagel reaction. Biochimie. 2011; 94(3):656-61. DOI: 10.1016/j.biochi.2011.09.018. View

15.

Nunomura A, Castellani R, Zhu X, Moreira P, Perry G, Smith M . Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006; 65(7):631-41. DOI: 10.1097/01.jnen.0000228136.58062.bf. View

16.

Gulcin I, Buyukokuroglu M, Kufrevioglu O . Metal chelating and hydrogen peroxide scavenging effects of melatonin. J Pineal Res. 2003; 34(4):278-81. DOI: 10.1034/j.1600-079x.2003.00042.x. View

17.

Jorge M, Madjarof C, Ruiz A, Fernandes A, Rodrigues R, de Oliveira Sousa I . Evaluation of wound healing properties of Arrabidaea chica Verlot extract. J Ethnopharmacol. 2008; 118(3):361-6. DOI: 10.1016/j.jep.2008.04.024. View

18.

Ames B . Dietary carcinogens and anti-carcinogens. J Toxicol Clin Toxicol. 1984; 22(3):291-301. DOI: 10.3109/15563658408992561. View